Finch Therapeutics Group, Inc. (FNCH) Ownership

$11.03

north_east
$0.01 (0.09%)
Day's range
$10.41
Day's range
$11.03

Finch Therapeutics Group, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LAKE STREET ADVISORS GROUP, LLC 08/05/2024 21,206 $29,052   0.00% 1.32%
WELLS FARGO & COMPANY/MN 08/13/2024 0 $0   -100.00% 0.00%
VANGUARD GROUP INC 08/13/2024 0 $0   -100.00% 0.00%
MORGAN STANLEY 10/17/2024 0 $0   -100.00% 0.00%
BLACKROCK INC. 08/13/2024 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/15/2024 0 $0   -100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 08/13/2024 0 $0   -100.00% 0.00%
UBS GROUP AG 08/14/2024 0 $0   -100.00% 0.00%
IKARIAN CAPITAL, LLC 08/14/2024 0 $0   -100.00% 0.00%
BLEICHROEDER LP 08/13/2024 0 $0   -100.00% 0.00%

Finch Therapeutics Group, Inc. institutional Ownership - FAQ's

During the previous two years, 4 institutional investors and hedge funds held shares of Finch Therapeutics Group, Inc.. The most heavily invested institutionals were:

BlackRock Inc.: 0

Avenir Management Company, LLC: 45,650

Amalgamated Financial Corp.: 942

FIRST MIDWEST BANK TRUST DIVISION: 0

1.32% of Finch Therapeutics Group, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 46,592 shares in the last 24 months. This purchase volume represents approximately $513,910 in transactions.